• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-PSMA-1007 PET/CT上不同前列腺区域的影像组学特征对前列腺癌患者持续前列腺特异性抗原的预测:一项多中心研究

Radiomics Features from Different Prostatic Zones on F-PSMA-1007 PET/CT for Predicting Persistent PSA in Prostate Cancer Patients: A Multicenter Study.

作者信息

Li Licong, Xu Jian, Bian Shuying, Yao Fei, Lin Qi, Zhou Meiyan, Yang Yunjun, Song Meiyao, Pan Yixuan, Shen Qinyang, Zhuang Yuandi, Lin Jie

机构信息

The Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

The Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

出版信息

Cancers (Basel). 2025 Aug 28;17(17):2807. doi: 10.3390/cancers17172807.

DOI:10.3390/cancers17172807
PMID:40940904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12427274/
Abstract

: This study aims to explore the role of radiomics features (RFs) from prostate subregions, including the tumor microenvironment (TME), in predicting persistent PSA. : In retrospective analysis, we segregated 354 patients with pathologically confirmed localized prostate cancer (PCa) into training, internal validation, and external validation cohorts. The prostate on F-prostate-specific membrane antigen (PSMA)-1007 positron emission tomography/computed tomography (PET/CT) was partitioned into three zones based on the maximum standardized uptake value (SUVmax) (zone-intra: 45-100% SUVmax; zone-peri: 20-45% SUVmax; zone-norm: 0-20% SUVmax). RFs from these zones were harnessed to develop five radiomics models [model-intra; model-peri; model-norm; model-ip; model-ipn]. Three optimal radiomics models were further integrated with the PSA model to construct combined models. Model performance was evaluated using the receiver operating characteristic (ROC) curves and the area under the curve (AUC). : Utilizing least absolute shrinkage and selection operator (LASSO) and logistic regression, five radiomics models were constructed, with model-ip, model-ipn, and model-intra showing superior performance [training cohort AUCs: 0.76 (0.68-0.83), 0.75 (0.68-0.83), 0.76 (0.68-0.83); internal validation cohort AUCs: 0.76 (0.65-0.88), 0.72 (0.57-0.86), 0.70 (0.55-0.86); external validation cohort AUCs: 0.70 (0.50-0.86), 0.55 (0.36-0.73), 0.53 (0.34-0.72)]. Notably, the combined model incorporating model-ip and the PSA model exhibited optimal performance [training cohort AUC: 0.78 (0.71-0.85); internal validation cohort AUC: 0.78 (0.67-0.90); external validation cohort AUC: 0.89 (0.72-0.98)]. : The RFs in different subregions on F-PSMA-1007 PET/CT have varying effectiveness in predicting persistent PSA. A radiomics model that encompasses the 20-45% SUVmax and 45-100% SUVmax zones, when combined with the PSA model, enhances predictive accuracy.

摘要

本研究旨在探讨前列腺亚区域(包括肿瘤微环境)的放射组学特征在预测持续性前列腺特异性抗原(PSA)方面的作用。

在回顾性分析中,我们将354例经病理证实的局限性前列腺癌(PCa)患者分为训练组、内部验证组和外部验证组。基于最大标准化摄取值(SUVmax),将F-前列腺特异性膜抗原(PSMA)-1007正电子发射断层扫描/计算机断层扫描(PET/CT)上的前列腺分为三个区域(区域内:45 - 100% SUVmax;区域周围:20 - 45% SUVmax;区域正常:0 - 20% SUVmax)。利用这些区域的放射组学特征开发了五个放射组学模型[模型内;模型周围;模型正常;模型ip;模型ipn]。进一步将三个最佳放射组学模型与PSA模型整合以构建联合模型。使用受试者工作特征(ROC)曲线和曲线下面积(AUC)评估模型性能。

利用最小绝对收缩和选择算子(LASSO)和逻辑回归构建了五个放射组学模型,模型ip、模型ipn和模型内表现出更好的性能[训练组AUC:0.76(0.68 - 0.83),0.75(0.68 - 0.83),0.76(0.68 - 0.83);内部验证组AUC:0.76(0.65 - 0.88),0.72(0.57 - 0.86),0.70(0.55 - 0.86);外部验证组AUC:0.70(0.50 - 0.86),0.55(0.36 - 0.73),0.53(0.34 - 0.72)]。值得注意的是,结合模型ip和PSA模型的联合模型表现出最佳性能[训练组AUC:0.78(0.71 - 0.85);内部验证组AUC:0.78(0.67 - 0.90);外部验证组AUC:0.89(0.72 - 0.98)]。

F-PSMA - 1007 PET/CT不同亚区域的放射组学特征在预测持续性PSA方面具有不同的有效性。一个包含20 - 45% SUVmax和45 - 100% SUVmax区域的放射组学模型与PSA模型相结合时,可提高预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/13a434c1e028/cancers-17-02807-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/50d1deae409c/cancers-17-02807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/8890e2149d14/cancers-17-02807-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/9f301911ee97/cancers-17-02807-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/e018a2739598/cancers-17-02807-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/46fdb5193915/cancers-17-02807-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/13a434c1e028/cancers-17-02807-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/50d1deae409c/cancers-17-02807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/8890e2149d14/cancers-17-02807-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/9f301911ee97/cancers-17-02807-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/e018a2739598/cancers-17-02807-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/46fdb5193915/cancers-17-02807-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00ed/12427274/13a434c1e028/cancers-17-02807-g006.jpg

相似文献

1
Radiomics Features from Different Prostatic Zones on F-PSMA-1007 PET/CT for Predicting Persistent PSA in Prostate Cancer Patients: A Multicenter Study.F-PSMA-1007 PET/CT上不同前列腺区域的影像组学特征对前列腺癌患者持续前列腺特异性抗原的预测:一项多中心研究
Cancers (Basel). 2025 Aug 28;17(17):2807. doi: 10.3390/cancers17172807.
2
Machine learning-based construction and validation of an radiomics model for predicting ISUP grading in prostate cancer: a multicenter radiomics study based on [68Ga]Ga-PSMA PET/CT.基于机器学习构建和验证用于预测前列腺癌ISUP分级的放射组学模型:一项基于[68Ga]镓-PSMA PET/CT的多中心放射组学研究
Eur J Nucl Med Mol Imaging. 2025 Jun 24. doi: 10.1007/s00259-025-07412-x.
3
Diagnostic value of [F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer.基于PRIMARY评分联合多参数磁共振成像的[F]PSMA - 1007 PET/CT在临床显著前列腺癌中的诊断价值
Front Oncol. 2025 Jun 18;15:1589212. doi: 10.3389/fonc.2025.1589212. eCollection 2025.
4
Radiomics Nomogram Based on Optimal Volume of Interest Derived from High-Resolution CT for Preoperative Prediction of IASLC Grading in Clinical IA Lung Adenocarcinomas: A Multi-Center, Large-Population Study.基于高分辨率 CT 最优感兴趣区体积的放射组学列线图预测临床 IA 期肺腺癌 IASLC 分级:多中心大样本研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241300734. doi: 10.1177/15330338241300734.
5
[Predictive value of CT-based tumor and peritumoral radiomics for WHO/ISUP grading of non-metastatic clear cell renal cell carcinoma].[基于CT的肿瘤及瘤周影像组学对非转移性透明细胞肾细胞癌WHO/ISUP分级的预测价值]
Zhonghua Yi Xue Za Zhi. 2025 Jul 15;105(26):2195-2202. doi: 10.3760/cma.j.cn112137-20250226-00460.
6
Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET/CT scans.利用治疗前PSMA-PET/CT扫描的原发肿瘤和淋巴结影像组学预测局限性前列腺腺癌患者的无转移生存期
Radiother Oncol. 2025 Sep 6;212:111119. doi: 10.1016/j.radonc.2025.111119.
7
The value of habitat analysis based on F-PSMA-1007 PET/CT images for prostate cancer risk grading.基于F-PSMA-1007 PET/CT图像的前列腺癌风险分级的栖息地分析价值。
BMC Med Imaging. 2025 Jul 21;25(1):293. doi: 10.1186/s12880-025-01829-4.
8
End-to-end [F]PSMA-1007 PET/CT radiomics-based pipeline for predicting ISUP grade group in prostate cancer.用于预测前列腺癌ISUP分级组的基于端到端[F]PSMA - 1007 PET/CT影像组学的流程
Abdom Radiol (NY). 2025 Apr;50(4):1641-1652. doi: 10.1007/s00261-024-04601-4. Epub 2024 Sep 30.
9
The value of radiomics and deep learning based on PET/CT in predicting perineural nerve invasion in rectal cancer.基于PET/CT的影像组学和深度学习在预测直肠癌神经周围侵犯中的价值。
Abdom Radiol (NY). 2025 Mar 7. doi: 10.1007/s00261-025-04833-y.
10
Predicting visceral pleural invasion in invasive adenocarcinoma with a maximum diameter ≤ 3 cm based on F-FDG PET/CT radiomics.基于F-FDG PET/CT影像组学预测最大直径≤3 cm的浸润性腺癌的脏层胸膜侵犯情况
Eur J Nucl Med Mol Imaging. 2025 Aug 14. doi: 10.1007/s00259-025-07511-9.

本文引用的文献

1
Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.PSMA PET 衍生参数与寡转移前列腺癌治疗患者结局的相关性。
Radiology. 2023 Dec;309(3):e231407. doi: 10.1148/radiol.231407.
2
Evaluating the value of F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard.评估 F-PSMA-1007 PET/CT 在使用组织病理学作为标准的前列腺癌检测和识别中的价值。
Cancer Imaging. 2023 Nov 3;23(1):108. doi: 10.1186/s40644-023-00627-x.
3
Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy.
根治性前列腺切除术后 PSA 持续存在的长期预后和治疗策略。
Ann Surg Oncol. 2023 Oct;30(11):6936-6942. doi: 10.1245/s10434-023-13780-1. Epub 2023 Jul 7.
4
Role of [Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer.[Ga]Ga-PSMA-11 PET 放射组学预测原发性前列腺癌术后 ISUP 分级的作用。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2548-2560. doi: 10.1007/s00259-023-06187-3. Epub 2023 Mar 18.
5
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses.通过整合单细胞和空间转录组分析来剖析免疫抑制性的人类前列腺肿瘤微环境。
Nat Commun. 2023 Feb 7;14(1):663. doi: 10.1038/s41467-023-36325-2.
6
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.PSMA PET/CT:前列腺癌成像 2.0 的 EANM 程序指南/ SNMMI 程序标准联合。
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486. doi: 10.1007/s00259-022-06089-w. Epub 2023 Jan 5.
7
Ga-PSMA-11 PET/CT Features Extracted from Different Radiomic Zones Predict Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer.从不同影像组学区域提取的镓-PSMA-11 PET/CT特征可预测晚期前列腺癌患者对雄激素剥夺治疗的反应。
Cancers (Basel). 2022 Oct 3;14(19):4838. doi: 10.3390/cancers14194838.
8
Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with F-PSMA-1007 PET: comparison among different volume segmentation thresholds.基于机器学习的放射组学预测 F-PSMA-1007 PET 多原发前列腺癌生物学特征:不同体积分割阈值的比较。
Radiol Med. 2022 Oct;127(10):1170-1178. doi: 10.1007/s11547-022-01541-1. Epub 2022 Aug 26.
9
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.欧洲及全球基于血清前列腺特异性抗原的前列腺癌早期检测:过去、现在与未来
Nat Rev Urol. 2022 Sep;19(9):562-572. doi: 10.1038/s41585-022-00638-6. Epub 2022 Aug 16.
10
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.趋化因子与细胞因子:前列腺癌发病机制中的轴心与同盟
Semin Cancer Biol. 2022 Nov;86(Pt 3):497-512. doi: 10.1016/j.semcancer.2022.02.017. Epub 2022 Feb 16.